{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:35:00Z","timestamp":1793745300326,"version":"4.6.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1053\/j.seminoncol.2022.04.001","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:49:33Z","timestamp":1651218573000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Radiation recall dermatitis: A review of the literature"],"prefix":"10.1053","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7303-3941","authenticated-orcid":false,"given":"RS","family":"Bhangoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1149-155X","authenticated-orcid":false,"given":"TW","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MM","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CS","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3897-3011","authenticated-orcid":false,"given":"TA","family":"DeWees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JD","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CE","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-574X","authenticated-orcid":false,"given":"SH","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MY","family":"Halyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2850-4126","authenticated-orcid":false,"given":"SE","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-5859","authenticated-orcid":false,"given":"WW","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0001","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2008.02.070","article-title":"Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial","volume":"72","author":"Haffty","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0002","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.24.4.544","article-title":"The effect of actinomycin D on cancer in childhood","volume":"24","author":"Tan","year":"1959","journal-title":"Pediatrics"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0003","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","article-title":"Characterizing the phenomenon of radiation recall dermatitis","volume":"59","author":"Camidge","year":"2001","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3747\/co.2008.201","article-title":"Radiation recall dermatitis: case report and review of the literature","volume":"15","author":"Hird","year":"2008","journal-title":"Curr Oncol"},{"issue":"11","key":"10.1053\/j.seminoncol.2022.04.001_bib0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1634\/theoncologist.2009-0090","article-title":"Radiation recall with anticancer agents","volume":"15","author":"Burris","year":"2010","journal-title":"Oncologist"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0006","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/phpp.12529","article-title":"Measurements of sun sensitivity in five European countries confirm the relative nature of Fitzpatrick skin phototype scale","volume":"36","author":"Bieliauskiene","year":"2020","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1-2","key":"10.1053\/j.seminoncol.2022.04.001_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4414\/smw.2005.10896","article-title":"Docetaxel-induced radiation recall dermatitis","volume":"135","author":"Kandemir","year":"2005","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0008","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMicm041058","article-title":"Images in clinical medicine. Radiation recall reaction after antimicrobial therapy","volume":"354","author":"Kang","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0009","first-page":"470","article-title":"Radiation recall dermatitis in a patient treated with dacarbazine","volume":"13","author":"Kennedy","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.04.001_bib0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/sj.leu.2402992","article-title":"Radiation recall phenomenon associated with arsenic trioxide","volume":"17","author":"Keung","year":"2003","journal-title":"Leukemia"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0011","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00000421-200010000-00020","article-title":"Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease","volume":"23","author":"Kharfan Dabaja","year":"2000","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0012","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1345\/aph.1P404","article-title":"Methotrexate-induced periorbital radiation recall","volume":"45","author":"Kiel","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3857\/roj.2017.00339","article-title":"Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat Oncol J"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0014","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/ijd.13513","article-title":"Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma","volume":"56","author":"Korman","year":"2017","journal-title":"Intl J Dermatol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0015","first-page":"183","article-title":"Recurrent episodes of recall dermatitis of irradiated breast after LHRH agonist administration","volume":"16","author":"Kostadima","year":"2011","journal-title":"J BUON"},{"issue":"7600","key":"10.1053\/j.seminoncol.2022.04.001_bib0016","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(69)91941-2","article-title":"Skin reaction to vinblastine","volume":"1","author":"Lampkin","year":"1969","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0017","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.prro.2014.11.002","article-title":"Radiation recall precipitated by iodinated nonionic contrast","volume":"5","author":"Lau","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clon.2008.11.001","article-title":"Chemotherapy-induced recall of cetuximab and radiation skin reaction","volume":"21","author":"Law","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0019","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/j.1365-4632.2012.05788.x","article-title":"Radiation recall dermatitis and pneumonitis induced by trastuzumab (Herceptin(R))","volume":"53","author":"Lee","year":"2014","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/ol.2010.195","article-title":"Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy","volume":"2","author":"Lock","year":"2011","journal-title":"Oncology Letters"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1346-8138.13238","article-title":"Exemestane-induced radiation recall dermatitis and morbilliform rash","volume":"43","author":"Marchand","year":"2016","journal-title":"J Dermatol"},{"issue":"11-12","key":"10.1053\/j.seminoncol.2022.04.001_bib0022","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0360-3016(76)90091-2","article-title":"Complications of irradiation related to apparent drug potentiation by adriamycin","volume":"1","author":"Mayer","year":"1976","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0023","first-page":"29","article-title":"Chemotherapy induced radiation recall reaction: a case report","volume":"10","author":"Mayuresh","year":"2018","journal-title":"Pravara Med Rev"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1096-911X(199609)27:3<185::AID-MPO9>3.0.CO;2-A","article-title":"Paclitaxel-induced radiation recall dermatitis","volume":"27","author":"McCarty","year":"1996","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.adro.2018.11.002","article-title":"Recurrent Radiation Recall Mucosal Toxicity of the Upper Aerodigestive Tract: A Case Report","volume":"4","author":"McGrath","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0026","article-title":"Radiation recall dermatitis in patients treated with sorafenib","volume":"2018","author":"Mehta","year":"2018","journal-title":"Case Rep Oncol Med"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ctrc.2014.11.005","article-title":"Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation","volume":"3","author":"Miller","year":"2015","journal-title":"Cancer Treatment Commun"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0028","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ijrobp.2006.05.073","article-title":"Frequency and characteristics of docetaxel-induced radiation recall phenomenon","volume":"66","author":"Mizumoto","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0029","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12282-013-0462-6","article-title":"Radiation recall dermatitis induced by trastuzumab","volume":"23","author":"Moon","year":"2016","journal-title":"Breast Cancer"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0030","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.2002.20.3.867","article-title":"Challenges in oncology. Case 2. Radiation recall associated with docetaxel","volume":"20","author":"Morkas","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0031","first-page":"48","article-title":"Docetaxel-associated radiation recall dermatitis","volume":"9","author":"Mulder","year":"2002","journal-title":"Curr Oncol"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0032","doi-asserted-by":"crossref","DOI":"10.5070\/D3215027527","article-title":"Ulcerated erythematous plaque on the right breast localized to the previously irradiated area","volume":"21","author":"Nakamura","year":"2015","journal-title":"Dermatol Online J"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0033","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/1097-0142(19920915)70:6<1605::AID-CNCR2820700627>3.0.CO;2-S","article-title":"Radiation recall associated with vinblastine in a patient treated for Kaposi sarcoma related to acquired immune deficiency syndrome","volume":"70","author":"Nemechek","year":"1992","journal-title":"Cancer"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0034","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.clon.2007.02.012","article-title":"Nimesulide\u2013a new trigger of radiation recall reaction","volume":"19","author":"Ng","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"13","key":"10.1053\/j.seminoncol.2022.04.001_bib0035","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2002.20.13.3029","article-title":"Treatment side effects. Case 1. Radiation recall phenomenon after administration of capecitabine","volume":"20","author":"Ortmann","year":"2002","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.04.001_bib0036","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1346-8138.2012.01576.x","article-title":"Drug eruption induced by gonadotropin-releasing hormone analogs accompanying radiation-recall phenomenon","volume":"39","author":"Oshima","year":"2012","journal-title":"J Dermatol"},{"issue":"8810","key":"10.1053\/j.seminoncol.2022.04.001_bib0037","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0140-6736(92)92460-W","article-title":"Radiation recall induced by tamoxifen","volume":"340","author":"Parry","year":"1992","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0038","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/07357909509024929","article-title":"Radiation recall dermatitis induced by edatrexate in a patient with breast cancer","volume":"13","author":"Perez","year":"1995","journal-title":"Cancer Invest"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0039","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.1995.13.1.305","article-title":"Radiation-recall dermatitis in a patient treated with paclitaxel","volume":"13","author":"Phillips","year":"1995","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0040","first-page":"438","article-title":"Radiation recall dermatitis from docetaxel","volume":"25","author":"Piroth","year":"2002","journal-title":"Onkologie"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0041","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1748-717X-1-32","article-title":"Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy \u2013 case report and review of literature","volume":"1","author":"Putnik","year":"2006","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0042","first-page":"71","article-title":"Sorafenib induced radiation recall dermatitis after spine radiosurgery","volume":"1","author":"Robbins","year":"2011","journal-title":"J Radiosurg SBRT"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0043","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1684\/ejd.2018.3295","article-title":"Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with nivolumab","volume":"28","author":"Rouyer","year":"2018","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0044","first-page":"82","article-title":"Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment?","volume":"31","author":"Samur","year":"2001","journal-title":"Turk J Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0090-8258(03)00404-9","article-title":"Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy","volume":"91","author":"Schwartz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0046","first-page":"31","article-title":"Erythema in areas of previous irradiation in patients treated with hydroxyurea (NSC-32065)","volume":"40","author":"Sears","year":"1964","journal-title":"Cancer Chemother Rep"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0047","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0190-9622(84)70134-4","article-title":"Drug eruptions presenting at sites of prior radiation damage (sunlight and electron beam)","volume":"11","author":"Shelley","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0048","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.1994.12.2.439","article-title":"Paclitaxel and radiation-recall dermatitis","volume":"12","author":"Shenkier","year":"1994","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.04.001_bib0049","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clon.2009.03.003","article-title":"Trastuzumab-induced radiation recall dermatitis\u2013first reported case","volume":"21","author":"Shrimali","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"10.1053\/j.seminoncol.2022.04.001_bib0050","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/1346-8138.13427","article-title":"Levetiracetam-induced radiation recall dermatitis in a patient undergoing stereotactic radiotherapy","volume":"43","author":"Sindoni","year":"2016","journal-title":"J Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0051","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1075-122X.2004.21222.x","article-title":"Tamoxifen-induced radiation recall dermatitis","volume":"10","author":"Singer","year":"2004","journal-title":"Breast J"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0052","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1752-1947-3-93","article-title":"Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report","volume":"3","author":"Spirig","year":"2009","journal-title":"J Med Case Rep"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0053","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0560.2006.00496.x","article-title":"Lipodermatosclerosis as a form of vascular compromise-associated radiation recall dermatitis: case report and a review of literature","volume":"33","author":"Sroa","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0054","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/1097-0142(19930215)71:4<1322::AID-CNCR2820710425>3.0.CO;2-Z","article-title":"Radiation recall skin toxicity with bleomycin in a patient with Kaposi sarcoma related to acquired immune deficiency syndrome","volume":"71","author":"Stelzer","year":"1993","journal-title":"Cancer"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00066-016-0950-7","article-title":"Radiation recall dermatitis induced by sorafenib: a case study and review of the literature","volume":"192","author":"Stieb","year":"2016","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0056","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1086\/520684","article-title":"Gemcitabine-related \"pseudocellulitis\": report of 2 cases and review of the literature","volume":"45","author":"Tan","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1053\/j.seminoncol.2022.04.001_bib0057","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1200\/JCO.2011.35.7202","article-title":"Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine","volume":"29","author":"Taunk","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0058","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s13691-016-0258-6","article-title":"Docetaxel and cyclophosphamide chemotherapy induced radiation recall phenomenon in a postoperative breast cancer patient: a case report","volume":"5","author":"Tomiguchi","year":"2016","journal-title":"International Cancer Conference Journal"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0059","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.canrad.2019.01.005","article-title":"Radiation recall syndrome in a patient with breast cancer, after introduction of everolimus","volume":"23","author":"Visy","year":"2019","journal-title":"Cancer Radiother"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3747\/co.v17i4.488","article-title":"Radiation recall dermatitis with azithromycin","volume":"17","author":"Vujovic","year":"2010","journal-title":"Current Oncology"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0061","first-page":"668","article-title":"Drug eruption localized to previously irradiated skin","volume":"71","author":"Vukelja","year":"1987","journal-title":"Cancer Treat Rep"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0062","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3816\/CBC.2010.n.054","article-title":"Levofloxacin-induced radiation recall dermatitis: a case report and a review of the literature","volume":"10","author":"Wernicke","year":"2010","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0063","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.prro.2010.12.003","article-title":"Radiation recall associated with insulin growth factor 1R antibody","volume":"1","author":"Wo","year":"2011","journal-title":"Pract Radiat Oncol"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0064","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0959-8049(96)00461-3","article-title":"Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold","volume":"33","author":"Yeo","year":"1997","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00128071-200001020-00006","article-title":"Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management","volume":"1","author":"Yeo","year":"2000","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0066","doi-asserted-by":"crossref","first-page":"188","DOI":"10.12788\/jcso.0044","article-title":"Gemicitabine-induced radiation recall phenomenon in 2 distinctive sites on the same patient","volume":"12","author":"Zhang","year":"2014","journal-title":"J Community Supportive Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0067","first-page":"202","article-title":"Radiation recall reaction: two case studies illustrating an uncommon phenomenon secondary to anti-cancer agents","volume":"9","author":"Zhu","year":"2012","journal-title":"Cancer Biol Med"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.04.001_bib0068","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00001813-200308000-00011","article-title":"Radiation recall dermatitis induced by pegylated liposomal doxorubicin","volume":"14","author":"Jimeno","year":"2003","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0069","first-page":"89","article-title":"Paclitaxel-induced radiation recall dermatitis","volume":"4","author":"Kandemir","year":"1999","journal-title":"J BUON"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0360-3016(02)02773-6","article-title":"Gemcitabine-induced radiation recall","volume":"53","author":"Jeter","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0071","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0936-6555(05)80545-X","article-title":"Radiation reaction recall following simvastatin therapy: a new observation","volume":"7","author":"Abadir","year":"1995","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0072","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13691-013-0099-5","article-title":"Radiation recall dermatitis: report of two cases","volume":"2","author":"Acevedo","year":"2013","journal-title":"Intl Cancer Conf J"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.04.001_bib0073","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1111\/1346-8138.14920","article-title":"Case of capecitabine-induced severe erosional radiation recall dermatitis in a patient with breast cancer","volume":"46","author":"Adachi","year":"2019","journal-title":"J Dermatol"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0074","doi-asserted-by":"crossref","first-page":"64","DOI":"10.12688\/f1000research.1-64.v2","article-title":"Capecitabine-induced radiation recall phenomenon: a case report","volume":"1","author":"Aguilar","year":"2013","journal-title":"F1000Research"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12538","article-title":"Radiation recall following cisplatin chemotherapy","volume":"163","author":"Alderman","year":"2013","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0076","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1075-122X.2006.00235.x","article-title":"Radiation recall dermatitis after the use of the anorexiant phentermine in a patient with breast cancer","volume":"12","author":"Ash","year":"2006","journal-title":"Breast J"},{"issue":"10","key":"10.1053\/j.seminoncol.2022.04.001_bib0077","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1634\/theoncologist.11-10-1118","article-title":"Radiation recall dermatitis with cefotetan: a case study","volume":"11","author":"Ayoola","year":"2006","journal-title":"Oncologist"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0078","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5021\/ad.2012.24.2.223","article-title":"Radiation recall dermatitis after treatment with paclitaxel and cisplatin","volume":"24","author":"Baek","year":"2012","journal-title":"Annals of Dermatology"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0079","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/030089160108700614","article-title":"Gemcitabine-induced radiation recall dermatitis: case report","volume":"87","author":"Bar-Sela","year":"2001","journal-title":"Tumori"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.lungcan.2006.06.021","article-title":"Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis","volume":"54","author":"Barlesi","year":"2006","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0081","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1078155208099705","article-title":"The use of sodium hyaluronate for the treatment of radiation recall dermatitis","volume":"15","author":"Bauer","year":"2009","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0082","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2007.08173.x","article-title":"Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide","volume":"157","author":"Bauza","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0083","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0973-1482.103529","article-title":"Gemcitabine-induced radiation recall phenomenon in a post-operative and post-radiotherapy case of peri-ampullary carcinoma during adjuvant chemotherapy","volume":"8","author":"Biswas","year":"2012","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0084","first-page":"1179","article-title":"Pemetrexed-induced radiation recall dermatitis of the breast","volume":"34","author":"Boesmans","year":"2014","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.04.001_bib0085","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.annonc.a010730","article-title":"Paclitaxel-induced radiation recall dermatitis","volume":"7","author":"Bokemeyer","year":"1996","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0086","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2133.2005.06801.x","article-title":"Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug?","volume":"153","author":"Borgia","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0087","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000372-200406000-00008","article-title":"Radiation recall dermatitis, panniculitis, and myositis following cyclophosphamide therapy: histopathologic findings of a patient affected by multiple myeloma","volume":"26","author":"Borroni","year":"2004","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.04.001_bib0088","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/028418699432653","article-title":"Radiation recall\u2013another call with tamoxifen","volume":"38","author":"Bostrom","year":"1999","journal-title":"Acta Oncol"},{"issue":"7","key":"10.1053\/j.seminoncol.2022.04.001_bib0089","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamadermatol.2013.4200","article-title":"Vemurafenib and radiosensitization","volume":"149","author":"Boussemart","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cup.12318","article-title":"Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption","volume":"41","author":"Braunstein","year":"2014","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0091","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.2000.18.3.693","article-title":"Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine","volume":"18","author":"Burstein","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0092","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.2000.18.3.695","article-title":"Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine","volume":"18","author":"Castellano","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0093","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/2278-0513.119247","article-title":"Paclitaxel-induced systemic muco-cutaneous reactions and radiation recall phenomenon","volume":"2","author":"Chatterjee","year":"2013","journal-title":"Clinical Cancer Investigation Journal"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0094","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.brachy.2009.01.001","article-title":"Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy","volume":"8","author":"Chen","year":"2009","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0095","first-page":"64","article-title":"Radiation recall reaction induced by levofloxacin","volume":"7","author":"Cho","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0096","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/CAD.0b013e328333d679","article-title":"Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib","volume":"21","author":"Chung","year":"2010","journal-title":"Anticancer Drugs"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0097","first-page":"317","article-title":"Chlorambucil-Induced Radiation Recall Dermatitis","volume":"13","author":"Clark","year":"2015","journal-title":"Skinmed"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0098","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000365918","article-title":"Vemurafenib-induced radiation recall dermatitis: case report and review of the literature","volume":"230","author":"Conen","year":"2015","journal-title":"Dermatology"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0099","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaad.2009.04.033","article-title":"Radiation recall dermatitis induced by erlotinib","volume":"61","author":"Dauendorffer","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/JTO.0b013e318170fcb9","article-title":"Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer","volume":"3","author":"Declercq","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0101","first-page":"449","article-title":"Complete urinary obstruction (CUO) and radiation recall dermatitis (RRD) associated with taxotere: Case report and literature review","volume":"32","author":"Duque","year":"2005","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0102","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/0284186X.2016.1246802","article-title":"Recall radiation myelitis after stereotactic radiation and dabrafenib in metastatic melanoma","volume":"56","author":"Ejlsmark","year":"2017","journal-title":"Acta Oncologica"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0103","first-page":"306","article-title":"Gemcitabine-induced rectus abdominus radiation recall","volume":"7","author":"Fakih","year":"2006","journal-title":"Jop"},{"issue":"2-3","key":"10.1053\/j.seminoncol.2022.04.001_bib0104","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0169-5002(01)00194-5","article-title":"Radiation recall reaction following gemcitabine","volume":"33","author":"Fogarty","year":"2001","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0105","first-page":"224","article-title":"Radiation recall associated with VP-16-213 therapy","volume":"63","author":"Fontana","year":"1979","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1078155212436591","article-title":"Successful rechallenge after ixabepilone-induced radiation recall dermatitis using an alternative dosing strategy","volume":"19","author":"Ford","year":"2013","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0107","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/CMR.0000000000000078","article-title":"Radiation recall dermatitis and radiation pneumonitis during treatment with vemurafenib","volume":"24","author":"Forschner","year":"2014","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0108","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.clbc.2013.12.011","article-title":"Radiation recall reaction with letrozole therapy in breast cancer","volume":"14","author":"Foster","year":"2014","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0109","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/gyno.1995.1139","article-title":"Radiation recall reaction to idarubicin resulting in vaginal necrosis","volume":"57","author":"Gabel","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/20009666.2019.1623627","article-title":"Nitrofurantoin-induced radiation recall dermatitis","volume":"9","author":"Garrahy","year":"2019","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"8","key":"10.1053\/j.seminoncol.2022.04.001_bib0111","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clon.2009.02.007","article-title":"A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon","volume":"21","author":"Ghosal","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"6","key":"10.1053\/j.seminoncol.2022.04.001_bib0112","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/1756-185X.12233","article-title":"Gemcitabine-induced radiation recall myositis in a patient with dermatomyositis","volume":"17","author":"Graf","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0113","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1503\/cmaj.090320","article-title":"Radiation recall dermatitis","volume":"182","author":"Guarneri","year":"2010","journal-title":"Cmaj"},{"issue":"4","key":"10.1053\/j.seminoncol.2022.04.001_bib0114","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/07357900802392667","article-title":"Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin","volume":"27","author":"Gzell","year":"2009","journal-title":"Cancer Invest"},{"issue":"2","key":"10.1053\/j.seminoncol.2022.04.001_bib0115","first-page":"72","article-title":"An illustrated case of doxorubicin-induced radiation recall dermatitis and a review of the literature","volume":"69","author":"Haas","year":"2011","journal-title":"Neth J Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0116","first-page":"49","article-title":"Acute erythema of the face after methotrexate","volume":"74","author":"Ham","year":"2016","journal-title":"Netherlands J Med"},{"issue":"5","key":"10.1053\/j.seminoncol.2022.04.001_bib0117","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamadermatol.2015.5366","article-title":"Radiation recall dermatitis with concomitant dabrafenib and pazopanib therapy","volume":"152","author":"Haraldsdottir","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1053\/j.seminoncol.2022.04.001_bib0118","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2147\/OTT.S64706","article-title":"Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy","volume":"7","author":"Hsieh","year":"2014","journal-title":"Onco Targets Ther"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0119","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2014.08.030","article-title":"Radiation-recall dermatitis with the everolimus\/exemestane combination ten years after adjuvant whole-breast radiotherapy","volume":"112","author":"Ioannidis","year":"2014","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.20379","article-title":"Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma","volume":"80","author":"Marisavljevic","year":"2005","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminoncol.2022.04.001_bib0121","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.2008.18.7724","article-title":"Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor","volume":"27","author":"Chi","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2022.04.001_bib0122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-013-2623-x","article-title":"Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT)","volume":"140","author":"Lei","year":"2013","journal-title":"Breast Cancer Res Treat"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775422000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775422000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:57:19Z","timestamp":1758805039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775422000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0093775422000264"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2022.04.001","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation recall dermatitis: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2022.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}